Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 346 | 0 | 0 | 0 | 0 |
| Gross Profit | 346 | N/A | N/A | N/A | N/A |
| Operating Expenses | 20,937 | 49,652 | 14,872 | 13,715 | 14,597 |
| Operating Income | -20,591 | -46,652 | -14,872 | -13,715 | -14,597 |
| Interest Expense | 201 | 53 | 683 | 1,500 | 1,420 |
| Other Income | -1,252 | 22 | 8,511 | 8 | 15 |
| Pre-tax Income | -22,044 | -46,683 | -7,044 | -15,207 | -16,002 |
| Net Income Continuous | -22,044 | -46,683 | -7,044 | -15,207 | -16,002 |
| Net Income | $-22,044 | $-46,683 | $-7,044 | $-15,207 | $-16,002 |
| EPS Basic Total Ops | -3.80 | -11.59 | -1.80 | -3.93 | -4.25 |
| EPS Basic Continuous Ops | -3.80 | -11.59 | -1.80 | -3.93 | -4.25 |
| EPS Diluted Total Ops | -3.80 | -11.59 | -1.80 | -3.93 | -4.25 |
| EPS Diluted Continuous Ops | -3.80 | -11.59 | -1.80 | -3.93 | -4.25 |
| EBITDA(a) | $-19,478 | $-48,456 | $-13,788 | $-12,616 | $-13,512 |